Skip to main content
. 2021 Feb 28;10(3):241. doi: 10.3390/antibiotics10030241

Table 1.

The prevalence of the virulence factor genes with respect to the presence of carbapenem resistance mechanisms (n = 107); (*)—a statistically significant difference (χ2 test) noted between the exoS gene frequency in the two strain subgroups is indicated (p < 0.001).

Subgroup Gene phzM phzS exoT exoY exoU toxA algD exoS * pilA pilB
Carbapenemase (−) n = 74 74 74 74 73 73 72 69 57 15 4
% 100.0 100.0 100.0 98.6 98.6 97.3 93.2 77.0 20.3 5.4
Carbapenemase (+) n = 33 33 33 33 33 33 31 30 6 2 1
% 100.0 100.0 100.0 100.0 100.0 93.9 90.9 18.2 6.1 3.0